Sort by
Refine Your Search
-
modalities including immune checkpoint blockade, cytokine-based immune modulation, and engineered cellular therapies such as CAR-T platforms. The scholar will contribute to the development and refinement
-
efforts will extend to therapeutic modalities including immune checkpoint blockade, cytokine-based immune modulation, and engineered cellular therapies such as CAR-T platforms. The scholar will contribute
-
, spectroscopy, and advanced materials research. These shared facilities foster collaborations across physics, chemistry, materials science, and engineering, enabling faculty and students to address complex
-
techniques, data analysis, and scientific communication. Required: PhD in chemistry, physics, biomedical engineering, or other related discipline. Past graduate or postdoctoral experience in spectroscopy and
-
interest is to develop Adeno-associated virus (AAV) vectors to treat various diseases such as ocular blindness, and to study basic biology and virus host interaction. A major focus is vector engineering to
-
that contribute to the immunosuppressive landscape, and engineer targeted therapeutics to modulate the TME for safer and more effective cancer treatment. These will include the use of biochemistry, cell biology
-
, Biostatistics, Clinical Trials Office, Clinical Treatment Unit/Clinical Trials Processing Lab, Comparative Pathology and Mouse Phenotyping, Genetically Engineered Mouse Modeling, Genomics, Leukemia Tissue Bank